A 55-year-old man with obesity, hypertension and type 2 diabetes is found to have elevated liver enzymes and ultrasound evidence of hepatic steatosis. Viral hepatitis serology is negative and he does not drink alcohol. According to current guidance on non-alcoholic fatty liver disease (NAFLD), what is the cornerstone of management?